Elections

US off-patent industry association the AAM has welcomed the prospect of working with the incoming Biden-Harris administration, emphasizing that there is “more to be done” to improve generic and biosimilar utilization and uptake.

Neither Kamala Harris nor Donald Trump mentioned drug pricing reforms in their presidential convention speeches.

The agency is clearly on the radar of former President Trump and his new coterie of tech moguls.

A round-up of the latest appointments across Europe's health and wellness markets: France's Gilbert appoints managing director; ProBiotix names marketing head; European Parliament elects committee chairs.

Marketing authorizations for OTC medicines could be rejected if their environmental risk assessments do not meet new requirements proposed within the EU pharma legislation revision. HBW Insight speaks to regulatory law experts Tine Carmeliet and Eline D'Joos to find out what you need to know about the new rules.

The Personal Care Products Council is actively working with the FDA’s cosmetics office director Linda Katz and principal deputy commissioner Namandje Bumpus to ensure the agency has the tools it needs to continue rolling out MoCRA, says Tom Myers, the association's president and CEO. Also, the 2024 US presidential election and the problem of misinformation.

The UK's consumer healthcare industry association, PAGB, sets out six priorities for the new UK government, following the landslide victory of the Labour Party in the recent general election. One of these priorities is driving Rx-to-OTC switch - something that the UK public also wants, according to the association's latest Self-Care Census, published to mark International Self-Care Day 2024.

Cosmetics Europe re-elected Isabelle Martin as President and Birgit Huber as VP during the trade association’s General Assembly in Brussels 20 June. The EU Green Deal and its numerous entanglements continue to loom large in the group’s strategic programming.

With the 4 July UK general election less than two weeks away, the Pink Sheet looks at the manifestos published by the major political parties and finds pledges to drive innovation, boost clinical trial activity and speed up regulatory procedures.

The European Federation of Associations of Health Product Manufacturers, EHPM, is hopeful the upcoming EU elections will trigger action on key issues related to dietary supplements, including novel food authorizations and harmonized vitamin levels.

The EU Parliament's Environment, Public Health and Food Safety committee proposes a “compromise amendment” to the new pharmaceutical directive that would include only antimicrobials for which there is an “identified risk of antimicrobial resistance” to the prescription requirement. 

While more significant reforms are less likely under a second Biden term unless Democrats control both chambers of Congress, former President Trump could look to put his stamp on drug pricing reform by resurrecting one of his former policies involving international reference pricing and Medicare Part B drugs. 

Infographic details who gave what to whom as all segments of the US healthcare industry gear up for the presidential election cycle.

President Biden’s call to expand the US Medicare price negotiation program is naturally making headlines from his campaign-year State of the Union Address. But his call for a national cap on co-pays could be an important opportunity for industry in the years to come.

The opposition Labour Party’s life sciences plan aims to make the UK a “frontier market” for innovative products, including cell and gene therapies. 

With European Parliament elections on the horizon, the coming 12 months will shape the EU policy agenda for dietary supplements regulation for the foreseeable future. Hylobates Consulting's managing director Luca Bucchini highlights some of the key issues which need addressing if Europe is ever going to achieve a harmonized, single market for supplements.

Former Trump advisor Joe Grogan discusses what might be in store for the biopharma industry if the former president is re-elected in 2024.

Granger’s exit means House Appropriations will have different chair no matter which party wins majority 2024 elections; Democrats will lose senior House Energy and Commerce Health Subcommittee member with Eshoo’s retirement.

Appropriations Agriculture, Rural Development, FDA and Related Agencies Subcommittee marked up its FY2024 bill on 18 May, proposing $6.579bn for FDA. Total is up from current budget of $6.562bn, but Biden administration proposed $7.2bn for FY2024.